Iranian Journal of Dermatology، جلد ۲۵، شماره ۳، صفحات ۲۲۱-۲۲۹

عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله

عنوان انگلیسی Efficacy assessment of topical brimonidine 0.33% in the treatment of rosacea in Middle Eastern patients with darker skin types
چکیده انگلیسی مقاله Background: Brimonidine tartrate is an alpha-2 adrenergic receptor agonist approved for treating rosacea. This study aimed to assess the efficacy and safety of a brimonidine gel in rosacea patients with skin types III and IV. Methods: This study was a phase II before-after clinical study in 20 patients with moderate to severe rosacea treated with brimonidine 0.33% gel. Clinician’s Erythema Assessment (CEA), Patients’ Self-Assessment (PSA), skin erythema (ΔE), lightness (ΔL), and biophysical parameters were measured before treatment and 4 and 8 weeks later. Ultrasound parameters were also measured at the same time points. Results: Eighteen patients completed the study. CEA and PSA decreased significantly from 3.05 to 2.10 and 2.15 after 4 weeks and 2.20 and 2.15 after 8 weeks, respectively (P<0.01 for both). Furthermore, ΔE and ΔL, as well as the skin erythema index, improved after 4 weeks of treatment. The skin echo density of both the epidermis and dermis also increased after 8 weeks (P<0.05). During the study, no serious adverse events occurred other than some reports of temporary moderate redness. Conclusion: Daily application of brimonidine 0.33% gel is safe and effective for the treatment of rosacea in darker skin types.
کلیدواژه‌های انگلیسی مقاله brimonidine,rosacea,Middle Eastern People,biophysical parameters

نویسندگان مقاله Saman Ahmad Nasrollahi |
Center for Research & Training in Skin Diseases & Leprosy, Tehran University of Medical Sciences, Tehran, Iran

Aniseh Samadi |
Center for Research & Training in Skin Diseases & Leprosy, Tehran University of Medical Sciences, Tehran, Iran

Fatemeh Samii |
Pharmaceutical Sciences Branch, Islamic Azad University, Tehran, Iran

Chao Yuan |
Skin & Cosmetic Research Department, Shanghai Skin Disease Hospital, Shanghai, China

Alireza Firooz |
Center for Research & Training in Skin Diseases & Leprosy, Tehran University of Medical Sciences, Tehran, Iran


نشانی اینترنتی https://www.iranjd.ir/article_164128_3bebf54946696fedf5e242e5e12627d0.pdf
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات